Bill > SB1301

This bill amends Pennsylvania's Title 35 (Health and Safety) to add a new chapter on medical devices. The key provisions include: 1. Prohibiting the manufacture, sale, or distribution of intravenous (IV) solution containers made with intentionally added di(2-ethylhexyl) phthalate (DEHP), a chemical used to add flexibility to plastics, starting January 1, 2026. 2. Prohibiting the manufacture, sale, or distribution of IV tubing made with intentionally added DEHP for use in neonatal intensive care units or for nutrition or oncology treatment infusions starting January 1, 2026, and completely prohibiting such tubing with intentionally added DEHP starting January 1, 2031. 3. Prohibiting the replacement of DEHP with other ortho-phthalates in new or revised medical devices. 4. Requiring healthcare practitioners to notify patients prior to using IV solution containers or tubing that contain DEHP or other ortho-phthalates, and to inform them of the associated risks and their right to request DEHP-free alternatives. The bill aims to address the potential health risks associated with exposure to DEHP, which has been linked to endocrine disruption, reproductive issues, and cancer.

Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2023&sind=0&body=S&type=B&bn=1301